Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
---|
05/27/1997 | US5633395 Chemically-defined non-polymeric valency platform molecules and conjugates thereof |
05/27/1997 | US5633365 Detection of amplified or deleted chromosomal regions |
05/27/1997 | US5633363 Root preferential promoter |
05/27/1997 | US5633362 Production of 1,3-propanediol from glycerol by recombinant bacteria expressing recombinant diol dehydratase |
05/27/1997 | US5633352 Biosynthetic human growth hormone |
05/27/1997 | US5633348 Amphotropic virus receptor |
05/27/1997 | US5633234 Lysosomal targeting of immunogens |
05/27/1997 | US5633229 Method of using prophenins-antibiotic peptides |
05/27/1997 | US5633227 Secretory leukocyte protease inhibitor as an inhibitor of tryptase |
05/27/1997 | US5633165 Fermentor with vertical shaft |
05/27/1997 | US5633161 Murine gene fomy030 coding for tumor progression inhibitor |
05/27/1997 | US5633158 Culture product; genetic engineering |
05/27/1997 | US5633157 Simple and efficient method for site-directed mutageneis with double-stranded plasmid DNA |
05/27/1997 | US5633156 Of eukaryotic cells |
05/27/1997 | US5633155 Expression vector for phytolacca antiviral protein and process for preparing transgenic plant transformed therewith |
05/27/1997 | US5633154 Method for location of insertion elements |
05/27/1997 | US5633153 Aldehyde dehydrogenase selectable markers for plant transformation |
05/27/1997 | US5633150 Preparation of functional human factor VIII |
05/27/1997 | US5633149 Polynucleotide encoding novel chemokine expressed in inflamed adenoid |
05/27/1997 | US5633147 Transforming growth factor αH1 |
05/27/1997 | US5633146 Genetic engineered yeast strains |
05/27/1997 | US5633145 TNFα receptor-derived binding protein |
05/27/1997 | US5633141 Assaying platelet factor 4 neutrophil agonists |
05/27/1997 | US5633138 Used to detect nucleic acids |
05/27/1997 | US5633133 Ligation with hammerhead ribozymes |
05/27/1997 | US5633131 Rapid detection of isoniazid resistance in mycobacterium tuberculosis probes for selecting nucleic acid encoding isoniazid resistance, and methods and kits |
05/27/1997 | US5633129 Electrophoretic detection and separation of mutant DNA using replaceable polymer matrices |
05/27/1997 | US5633076 Maturing bovine ovum in vitro, forming zygote, introducing transgene into zygote, maturing to form embryo, transplanting embryo into female bovine |
05/27/1997 | US5632994 Fas associated proteins |
05/27/1997 | US5632993 Immunogens and the use thereof for obtaining antibodies against HbA1c |
05/27/1997 | US5632989 Screening with a monoclonal antibodies |
05/27/1997 | US5632982 Cytotoxic enhancement of TNF with copper |
05/27/1997 | CA2070591C Yogourt |
05/27/1997 | CA1339047C Production of erythropoietin |
05/23/1997 | CA2190706A1 Transfection of cells |
05/22/1997 | WO1997018475A1 Compounds and methods for the detection and prevention of t. cruzi infection |
05/22/1997 | WO1997018334A2 Nucleic acid probes complementary to human papillomavirus nucleic acid and related methods and kits |
05/22/1997 | WO1997018333A1 Disruption of expression of multiple alleles of mammalian genes |
05/22/1997 | WO1997018330A1 METHOD OF INTRAFAMILY FRAGMENT ANALYSIS OF THE T CELL RECEPTOR α AND β CHAIN CDR3 REGIONS |
05/22/1997 | WO1997018328A1 A method of sequencing |
05/22/1997 | WO1997018326A1 Ultrahigh resolution comparative nucleic acid hybridization to combed dna fibers |
05/22/1997 | WO1997018325A1 In situ hybridization to detect specific nucleic acid sequences in eucaryotic samples |
05/22/1997 | WO1997018322A2 Method of quantifying tumour cells in a body fluid and a suitable test kit |
05/22/1997 | WO1997018319A1 Joint expression of gtp cyclohydrolase and tyrosine hydroxylase |
05/22/1997 | WO1997018318A1 Method for gene introduction into target cells by retrovirus |
05/22/1997 | WO1997018317A1 Dodecahedral adenoviral protein complex, composition containing same and uses thereof |
05/22/1997 | WO1997018316A1 Expression system in microorganism and its use for expressing heterologous and homologous proteins |
05/22/1997 | WO1997018315A1 Hybrid factor viii with modified activity |
05/22/1997 | WO1997018314A1 Process for the preparation of peptides by way of streptavidin fusion proteins |
05/22/1997 | WO1997018313A1 Mch3, an apoptotic protease, nucleic acids encoding and methods of use |
05/22/1997 | WO1997018312A1 Chimeric oligomers having an rna-cleavage activity |
05/22/1997 | WO1997018311A1 Polyvalent anti-dengue vaccine |
05/22/1997 | WO1997018310A1 Plant gene involved in auxin related signalling pathways |
05/22/1997 | WO1997018309A1 E6 binding proteins |
05/22/1997 | WO1997018308A2 K-atp channel protein and methods relating to it |
05/22/1997 | WO1997018307A1 Fas ligand fusion protein |
05/22/1997 | WO1997018306A1 Crf analogs and their use in photoaffinity labeling of crf receptors |
05/22/1997 | WO1997018305A2 Method to prepare drug-resistant, non-malignant hematopoietic cells |
05/22/1997 | WO1997018304A1 Methods for modulation of cholesterol transport |
05/22/1997 | WO1997018302A1 METHOD OF PRODUCING α2,3-SIALYLTRANSFERASE |
05/22/1997 | WO1997018301A1 Synthetic hpv11 virus-like particles |
05/22/1997 | WO1997018300A2 Murine model for human carcinoma |
05/22/1997 | WO1997018293A1 Extraction system and method |
05/22/1997 | WO1997018241A1 Inducing resistance to tumor growth with soluble igf-1 receptor |
05/22/1997 | WO1997018240A1 Glial cell line-derived neurotrophic factor receptors |
05/22/1997 | WO1997018237A1 Chemokine from niddm pancreas |
05/22/1997 | WO1997018233A1 Method for producing a correctly folded, biological active recombinant protein |
05/22/1997 | WO1997018230A1 Cloning and expression of beta app-c100 receptor (c100-r) |
05/22/1997 | WO1997018229A1 Parasitic helminth macrophage migration inhibitory factor proteins, nucleic acid molecules, and uses thereof |
05/22/1997 | WO1997018228A1 The transcriptional promoter of the obesity gene |
05/22/1997 | WO1997018227A1 Type ix collagen and fragments thereof |
05/22/1997 | WO1997018226A1 Integrated nucleic acid hybridization devices based upon active surface chemistry |
05/22/1997 | WO1997018185A1 Lipopolyamines as transfection agents and pharmaceutical uses thereof |
05/22/1997 | WO1997017994A1 Treatment of diabetes with a glucokinase gene |
05/22/1997 | WO1997017988A1 Type ix collagen and chimeras |
05/22/1997 | WO1997017983A1 Methods of treating disorders of non-visual sensory epithelia |
05/22/1997 | WO1997017982A1 Methods and compositions for hair growth promotion |
05/22/1997 | WO1997017979A1 Methods for diagnosis and treatment of bloom's syndrome |
05/22/1997 | WO1997017937A2 Gene-therapeutic nucleic acid construct, production of same and use of same in the treatment of heart disorders |
05/22/1997 | WO1997017844A1 Composition for gene introduction and method for gene introduction by using the composition |
05/22/1997 | WO1997017843A1 Process for constructing transgenic animals |
05/22/1997 | WO1997017842A1 Production of somatic mosaicism in mammals using a recombinatorial substrate |
05/22/1997 | WO1997012961A3 Growth of adult pancreatic islet cells with laminin 5 |
05/22/1997 | WO1997012512A3 Transformation of cotton plants |
05/22/1997 | WO1997010056A3 Device and method for dna amplification and assay |
05/22/1997 | WO1997008314A3 Telomere repeat binding factor and diagnostic and therapeutic use thereof |
05/22/1997 | WO1997008304A3 Methodology to produce, purify and assay polypeptides with the proteolytic activity of the hcv ns3 protease |
05/22/1997 | WO1997007213A3 Assay for identifying genes causing chromosome non-disjunction |
05/22/1997 | WO1997007135A3 Binding of osteogenic protein-i (op-1) and analogs thereof to the cell surface receptor alk-1 and analogs thereof |
05/22/1997 | WO1997006265A3 Recombinant clone selection system |
05/22/1997 | WO1997005252A3 Chimeric receptors and methods for identifying compounds active at metabotropic glutamate receptors and the use of such compounds in the treatment of neurological disorders and diseases |
05/22/1997 | WO1997005241A3 Methods and compositions for identifying morphogen analogs |
05/22/1997 | WO1996041606A3 Improved pharmaceutical compositions for gene therapy |
05/22/1997 | WO1996038567A3 Dna sequence of a gene of hydroxy-phenyl pyruvate dioxygenase and production of plants containing a gene of hydroxy-phenyl pyruvate dioxygenase and which are tolerant to certain herbicides |
05/22/1997 | CA2240192A1 Methods for screening compounds that modulate cholesterol transport |
05/22/1997 | CA2238007A1 Cloning and expression of .beta.app-c100 receptor (c100-r) |
05/22/1997 | CA2237998A1 Chemokine from niddm pancreas |
05/22/1997 | CA2237900A1 Type ix collagen and chimeras |
05/22/1997 | CA2237891A1 Nucleic acid probes complementary to human papillomavirus nucleic acid and related methods and kits |
05/22/1997 | CA2237862A1 Method of producing .alpha.2,3-sialyltransferase |